Report LibraryAll Reports
Datamonitor Healthcare Infectious Disease KOL Interviews
Retail Price: $599.00*BioMedTracker Subscriber Price: $399.00 - click here to log in
December 01, 2017Datamonitor Healthcare interviewed two experts on infectious disease based in the UK and US to gauge their views on currently available treatment options, pipeline drugs, and challenges with clinical trial design in infectious disease. The specific drugs discussed include Triumeq [GSK], Genvoya [GILD], Descovy [GILD], BIC/F/TAF [GILD], Symtuza [JNJ], Tivicay/Edurant [GSK], Tivicay/Epivir [GSK], Cabotegravir/rilprivine [GSK], Fostemsavir [GSK], and DOR/3TC/TDF [MRK]. The two interviews were combined into a single report.
Biomedtracker will be offering KOL Reports and Physician Pulse Surveys for purchase a la carte, or access to all reports and surveys can be purchased as a subscription to KOL Insight. For more information on KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (858) 200-2357.
For our disclosures, please read the Biomedtracker Research Standards.
|Disease Group Covered:||Infectious disease|